Renal Cell Carcinoma (RCC): Current Approach to First Line Therapy and Beyond
Petros Grivas, MD, PhD
Liquid Biopsy: Advances in the Last Decade and Future Directions
Edgardo S. Santos Castillero, MD, FACP
Seven Years of Biosimilar Experience in the U.S., Where Untapped Value Remains
Jorge J. García, PharmD, MS, MHA, MBA, FACHE
Integrative Oncology: Treatment Approaches for Stress in Cancer Patients and Survivors
Ashwin Mehta, MD, MPH
Immunotherapy in Advanced NSCLC: Initial Therapy and How to Overcome Resistance
George Simon, MD, FACP, FCCP
